Vijay Satyanand Pande - 07 Aug 2025 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Role
Director
Signature
/s/ Dov A. Goldstein as attorney-in-fact
Issuer symbol
BIOA
Transactions as of
07 Aug 2025
Net transactions value
$0
Form type
4
Filing time
11 Aug 2025, 16:14:24 UTC
Previous filing
03 Oct 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pande Vijay Satyanand Director C/O BIOAGE LABS, INC., 1445A SOUTH 50TH STREET, RICHMOND /s/ Dov A. Goldstein as attorney-in-fact 11 Aug 2025 0001840663

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOA Stock Option (Right to Buy) Award $0 +22,000 $0.000000 22,000 07 Aug 2025 Common Stock 22,000 $4.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The entire option award shall vest on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date.